Gb Sciences Identifies Novel Cannabis-Inspired Mixtures That Could Treat Viral Infections
GB Sciences, Inc. (OTCQB: GBLX), a leading plant-inspired, biopharmaceutical R & D development company recently published a study that demonstrates the potential of selected cannabinoids and terpenes to reduce inflammation.
